Microbix Biosystms (MBX) Stock Statistics & Valuation Metrics

Microbix Biosystms has a market cap or net worth of C$33.31M. The enterprise value is C$0.00.

Microbix Biosystms has 138,806,340 shares outstanding. The number of shares has decreased by -2.65% in one year.

Microbix Biosystms’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

The current PE Ratio of Microbix Biosystms is ―. Microbix Biosystms’s PEG ratio is 0.00.

In the last 12 months, Microbix Biosystms had revenue of 18.59M and earned -2.25M in profits. Earnings per share was -0.02.

In the last 12 months, operating cash flow was -80.29K and capital expenditures -797.29K, giving a free cash flow of -877.58K billion.

Microbix Biosystms pays an annual dividend of ―, resulting in a dividend yield of ―

Microbix Biosystms upcoming earnings date is Feb 12, 2026, TBA (Confirmed).

Microbix Biosystms as a current ratio of ―, with Debt / Equity ratio of 21.85%

In the past 12 months, Microbix Biosystms has paid -55.73K in taxes.

Microbix Biosystms EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.

Microbix Biosystms has C$12.11M in cash and marketable securities with C$6.77M in debt, giving a net cash position of C$5.34M billion.

Gross margin is 55.77%, with operating margin of ―, and net profit margin of ―.

The average price target for Microbix Biosystms is C$0.50, which is 11.43% higher than the current price. The consensus rating is Moderate Buy